Isoproterenol administration in animal models induces dose- and time-dependent morphological and functional myocardial alterations ranging from physiological hypertrophy to congestive heart failure.
Review of animal models of myocardial injury induced by systemic beta-adrenergic receptor agonist (isoproterenol) administration.
Isoproterenol vs Vehicle/Control (Low (0.3-6 mg/kg), medium (10-85 mg/kg), and high (150-300 mg/kg) doses)
The animal models of myocardial injury induced by systemic β-adrenergic receptor agonist administration represent an experimental approach of persisting interest. These models were found useful especially for studies of structural and functional adaptation of myocardium during the progression of cardiac adaptive response towards maladaptive hypertrophy and insufficiency. The pathological alterations induced by isoproterenol (ISO) do not develop evenly. The ISO models may contribute effectively to understanding of pathologies in signal transduction, energetics, excitability and contractility that may contribute concomitantly to cardiac dysfunction and heart failure. In this minireview we focused on the alterations in general characteristics and heart function as well as on the morphological changes of cardiomyocytes developed during ISO administration. The morphological alterations within the cellular macro- and microdomains correspond to the electrical remodelling and contractile dysfunction of ventricular myocardium that could be used to identify pathological changes ranging from hypertrophy to failing heart.
Building similarity graph...
Analyzing shared references across papers
Loading...
Zuzana Nichtová
Thomas Jefferson University
Marta Novotová
Slovak Academy of Sciences
Eva Kráľová
Comenius University Bratislava
General Physiology and Biophysics
Slovak Academy of Sciences
Comenius University Bratislava
Institute of Chemistry of the Slovak Academy of Sciences
Building similarity graph...
Analyzing shared references across papers
Loading...
Nichtová et al. (Sun,) conducted a review in Experimental myocardial injury. Isoproterenol vs. Vehicle/Control was evaluated. Isoproterenol administration in animal models induces dose- and time-dependent morphological and functional myocardial alterations ranging from physiological hypertrophy to congestive heart failure.
synapsesocial.com/papers/6a227fe3ffccceb004b73211 — DOI: https://doi.org/10.4149/gpb_2012_015
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: